Halloween has come and gone in the US, and Americans are now gearing up for Thanksgiving and Christmas. But before the holiday season could get underway, the country went through a major political event with far-reaching implications: the midterm elections.As…
Kowa said on June 30 that it has won regulatory approval in Singapore for its combination eye drop Gla-Alpha (ripasudil + brimonidine) for the treatment of open angle glaucoma and ocular hypertension. The approval was granted on June 25.According to…
To read the full story
Related Article
- Gla-Alpha Launched in Singapore via Kowa: DWTI
January 14, 2026
- Kowa Releases Glaucoma Drug Gla-Alpha in Malaysia
December 18, 2025
BUSINESS
- Tanabe to Wind Down NeuroDerm, Scrap EU Launch of Parkinson’s Drug
November 19, 2026
- Shionogi Narrows R&D Pipeline to 21 Priority Programs Across 3 Disease Areas
November 19, 2026
- Toho, SDF Hospital Conduct Emergency Drug Supply Drill
November 19, 2026
- Japan Clears Fujirebio’s Blood-Based Aβ42 Test for Alzheimer’s
November 19, 2026
- Sobi Japan to Take Over Orfadin from Astellas in December
November 19, 2026





